Ziyond Pharmaceutical Co., Ltd.

江苏知原药业股份有限公司

Develops and commercializes topical dermatology pharmaceuticals and medical-grade skincare products in China, covering over 50 products across six therapeutic areas with an omnichannel network; per Frost & Sullivan, it has the broadest coverage of high-prevalence skin indications in China.

Filings

The documents are on HKEXnews; we link to the originals.

Matters the filing discloses

From the company’s latest filing; open a kind of matter to see how other companies disclosed it.

• Customer concentration
• Overlapping customers and suppliers
• Connected or related major customers / suppliers
• Distribution model
• Reliance on platforms, partners or licences
• Single product, business line or region
• Outsourced production (OEM / contract manufacturing)
• Business changes and acquisitions
• Capacity and utilisation
• Working capital: receivables, prepayments and cash cycle
• Inventory level and ageing
• Goodwill, intangibles and asset impairment
• Non-IFRS measures and adjustments
• Related-party transactions and balances